018 Impact of biologic therapies on the quality of life of psoriasis patients: results from the British Association of Dermatologists’ Biologic Interventions Register

Ireny Iskandar; Richard B. Warren; Mark Lunt; Kathleen McElhone; Catherine Smith; N. Reynolds; Christopher Em Griffiths; Darren M. Ashcroft

doi:10.1016/j.jid.2016.06.035

Back

Shared by

Christopher Em Griffiths

018 Impact of biologic therapies on the quality of life of psoriasis patients: results from the British Association of Dermatologists’ Biologic Interventions Register

Article 2016 en

Authors

II
Ireny Iskandar
RW
Richard B. Warren
ML
Mark Lunt

Related publications

Article2014

Baseline characteristics of patients with psoriasis enrolled in the British Association of Dermatologists' Biologic Interventions Register.

Ireny Iskandar, Richard B. Warren, Zenas Z N Yiu, Jnwn Barker, David Burden, A.D. Ormerod, Nick J. Reynolds, Catherine Smith, Christopher Em Griffiths, Darren M. Ashcroft

Article2014

Baseline characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Ireny Iskandar, Richard B. Warren, Zenas Z N Yiu, Jnwn Barker, David Burden, A.D. Ormerod, NJ Reynolds, Catherine Smith, Christopher Em Griffiths, Darren M. Ashcroft

Article2017

Real-world use of fumaric acid esters in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

K.J. Mason, Mark Lunt, H.J.A. Hunter, Zarif K. Jabbar‐Lopez, Brian Kirby, C. Elise Kleyn, Sophie Kreppel, Kathleen McElhone, Nick J. Reynolds, Richard B. Warren, Christopher Em Griffiths

Article2017

Real-world use of fumaric acid esters (FAE) in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

K.J. Mason, Mark Lunt, H.J.A. Hunter, Zarif K. Jabbar‐Lopez, Brian Kirby, C. Elise Kleyn, Sophie Kreppel, Kathleen McElhone, Nick J. Reynolds, Richard B. Warren, Christopher Em Griffiths

Article2017

001 Risk of serious infection associated with biologic therapies in psoriasis: A prospective cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Zenas Z N Yiu, Catherine Smith, A.D. Ormerod, Darren M. Ashcroft, Mark Lunt, Shernaz Walton, Rachel Murphy, Nick J. Reynolds, Christopher Em Griffiths, Richard B. Warren

018 Impact of biologic therapies on the quality of life of psoriasis patients: results from the British Association of Dermatologists’ Biologic Interventions Register

Discussion(0)

Related publications

Baseline characteristics of patients with psoriasis enrolled in the British Association of Dermatologists' Biologic Interventions Register.

Baseline characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Real-world use of fumaric acid esters in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Real-world use of fumaric acid esters (FAE) in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

001 Risk of serious infection associated with biologic therapies in psoriasis: A prospective cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)